Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/21535
Title: Fluorouracil and leucovorin with or without interferon alfa-2a as adjuvant treatment, in patients with high-risk colon cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Adult,Aged,Antimetabolites, Antineoplastic/administration & dosage,Antineoplastic Combined Chemotherapy Protocols/adverse effects/*therapeutic use,Colonic Neoplasms/*drug therapy/pathology,Disease-Free Survival,Female,Fluorouracil/administration & dosage,Humans,Interferon-alpha/administration & dosage/adverse effects/*therapeutic use,Leucovorin/administration & dosage,Male,Middle Aged,Neoplasm Staging,Prognosis,Recombinant Proteins,Survival Analysis,Treatment Outcome
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/21535
ISSN: 0030-2414
Link: http://www.ncbi.nlm.nih.gov/pubmed/10765125
http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowPDF&ArtikelNr=000012105&Ausgabe=225135&ProduktNr=223857&filename=000012105.pdf
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Fountzilas-2000-Fluorouracil and leu.pdf339.28 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons